Skip to main content
. Author manuscript; available in PMC: 2021 Dec 23.
Published in final edited form as: Acta Biomater. 2019 Aug 13;99:18–32. doi: 10.1016/j.actbio.2019.08.020

Table 3.

Summary of previously reported 3D models to elucidate key biological steps involved in bone metastases using different biomaterials.

Question Cancer model Biomaterials Refs.

How does bone tissue recruit metastatic cancer cells? Breast cancer Fibrin [87,102]
Prostate Cancer PCL [91]
How does the bone matrix modulate cancer phenotype? Breast cancer Chitosan + Hydroxyapatite [44]
Poly-ether-urethane [90]
PLG + Hydroxyapatite [42,43]
PEGDA + Hydroxyapatite [94]
Gelatin + Hydroxyapatite [88]
Prostate cancer PCL [91]
Collagen + Hydroxyapatite [95,121]
PCL-TCP + PEGDA [92]
Hyaluronan [89]
Decellularized bone [97]
PCL/gelatin [93]
Silk [119]
How do cancer cells destroy bone tissue? Breast Cancer PLG + Hydroxyapatite [42,43]
Gelatin + Hydroxyapatite [88]
Prostate Cancer PCL [91]
Decellularized bone [97]
Silk [119]

PCL: poly(ε-caprolactone); PLG: poly(lactide-co-glycolide); PEGDA: poly(ethylene glycol) diacrylate; TCP: Tricalcium phosphate.